CON (“The window is closed”)

In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed

Ariel W. Aday, Nicole E. Rich, Arjmand R. Mufti, Shannan R. Tujios

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)123-127
Number of pages5
JournalClinical Liver Disease
Volume11
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Ascites
Fibrosis

ASJC Scopus subject areas

  • Hepatology

Cite this

@article{7120fec8ca2c4eab9be4beca902b1dd9,
title = "CON (“The window is closed”): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed",
author = "Aday, {Ariel W.} and Rich, {Nicole E.} and Mufti, {Arjmand R.} and Tujios, {Shannan R.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1002/cld.699",
language = "English (US)",
volume = "11",
pages = "123--127",
journal = "Clinical Liver Disease",
issn = "2046-2484",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - CON (“The window is closed”)

T2 - In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed

AU - Aday, Ariel W.

AU - Rich, Nicole E.

AU - Mufti, Arjmand R.

AU - Tujios, Shannan R.

PY - 2018/5/1

Y1 - 2018/5/1

UR - http://www.scopus.com/inward/record.url?scp=85048328845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048328845&partnerID=8YFLogxK

U2 - 10.1002/cld.699

DO - 10.1002/cld.699

M3 - Review article

VL - 11

SP - 123

EP - 127

JO - Clinical Liver Disease

JF - Clinical Liver Disease

SN - 2046-2484

IS - 5

ER -